Conferences &
Events
Upcoming conferences and events
Previous conferences and events
Jan 25-27, 2023
PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.
Speaker(s): Sharon Benzeno, PhD; Nitin Sood
Topic(s): Gene Modified Cell Therapies Track (January 26, 9:00am – 4:30pm PT); Transforming Care for Lymphoid Cancer Patients Using MRD (January 27, 9:45am – 10:00am PT)
Dec 10-13, 2022
With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
Nov 8-12, 2022
Annual meeting provides a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.
Sep 19-22, 2022
The CAR-TCR Summit focuses on discovery through commercialization of safe, effective and commercially viable CAR and TCR therapies. Tracks include Discovery, Translation, Clinical Management, Early Phase Development, Manufacturing, CMC/Analytics, Logistics, and Market Access.
Speaker: Erik Yusko, PhD (Sr Director, Drug Discovery)
Sep 7-8, 2022
The Disease Prevention & Control Summit is a chance to partner, learn, connect, and make great strides towards preventing and combating infectious disease outbreaks of today and tomorrow.
Speaker: Katie Boland, PhD (Director, Business Development)
June 28-30, 2022
PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.
Speaker: Sharon Benzeno, PhD
Topic: Cell-based Therapy Challenges (Panel)
June 21-22, 2022
LSX aims to provide the world’s most influential and powerful global platform that will nurture and develop cross-industry partnerships, connect innovation to capital and forge and deepen relationships that will underpin the success of the global life science and healthcare industries.
Speaker: Sharon Benzeno, PhD
Topic: ‘Commercializing in the US’ table (June 22nd, 12:10pm), ‘Company Panel: When and why to build clinical and commercial support’ (June 22nd, 9:45am)
June 21-24, 2022
Federation of Clinical Immunology Societies (FOCIS) 2022 Annual Meeting
The FOCIS Annual Meeting brings together researchers and clinicians in translational immunology to share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected with immune-mediated diseases.
Speaker: Harlan Robins, PhD
June 13-16, 2022
Speaker: Sharon Benzeno, PhD
Topic(s): Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now (June 14th, 1:45 – 2:45pm PT)
Despite mounting evidence that we need to look at the entire immune response, many academics, government researchers and vaccine makers are failing to include T-cell metrics in their studies. As a result, key questions remain unanswered: How long do vaccines last? Does everyone need a booster?
ASCO offers presentations on the latest research in cancer care. This year’s program will feature sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through Innovation.
May 19 – 20, 2022
Convening the world’s leading clinicians, industry executives, investors, patient advocates, payers, policy experts, and researchers, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific, business, and policy issues influencing the status and outlook for personalized medicine in the wake of a devastating pandemic that has upended the health care landscape.
Speaker: Catherine Sanders, PhD
Topic(s): COVID-19 and the Next Steps for Medicine: A Panel Discussion About Personalized Medicine in the Post-Pandemic Era (May 19th, 10:15am ET)
Molecular diagnostics, more sophisticated approaches to analyzing health care data, and molecularly guided treatments for non-oncologic indications are expanding the frontiers of personalized medicine outside of oncology. But progress remains uneven across disease states. During this panel discussion, leaders in the field will join us to explore the opportunities and challenges for personalized medicine in multiple disease states.
Life Science Innovation Northwest is the Pacific Northwest’s largest annual life science conference bringing together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community for a two-day event to discuss and feature some of the most compelling technology breakthroughs of our time.
Speaker: Harlan Robins, PhD; Mark Adams, PhD
Topic(s): Next Frontier for Cell Therapies and Autoimmune Disorders (April 21st, 1:10pm – 2:00pm PT), Diagnostics (April 20th, 10:00am – 12:00pm PT)
April 18-21, 2022
World Vaccine Congress 2022
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.
Speaker(s): Sharon Benzeno, PhD; Patrick Raber, PhD
Topic(s): Immune Profiling: Lessons learned from the coronavirus pandemic to help inform future vaccine development (April 20th, 9:10am); T-cell Immune Response: Exploring emerging themes in vaccine development and COVID-19 variants (April 20th, 3:40pm)
- What have we learnt from monitoring the immune responses to SARS-CoV-2 vaccines in different populations?
- How can this help inform future vaccine development?
- Why did the majority of mRNA vaccines work so well? What research has been done to understand the efficacy of these vaccines?
April 8-13, 2022
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Speaker: Patrick Raber, PhD
Topic(s): Adaptive Symposium: Advancing cancer and immunotherapy research with immunosequencing
Mar 16-18, 2022
IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.
Speaker: Sharon Benzeno PhD
Topic(s): Antigen-specific TCR discovery at scale to inform immune-based therapies (March 17 4:45pm ET); Assessing the Opportunities for IO 2.0 (March 17, 12:05pm ET)
Jan 10th, 2022 @ 1:30pm (EST)
Speaker: CEO and Co-founder Chad Robins
Dec 11-14, 2021
The premier event in malignant and non-malignant hematology. Join us at the Georgia World Congress Center in Atlanta, Georgia – or virtually – from December 11-14, 2021, to discover the newest advances in hematology.
Nov 30-Dec 1, 2021
The World Vaccine & Immunotherapy Congress is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe.
Speaker(s): Sharon Benzeno PhD; Lance Baldo MD
Topic(s): TCRs from discovery to therapeutics (Sharon Benzeno, Nov 30, 3:10 pm)
Nov 10-Nov 14, 2021
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C.
Nov 10, 2021 @ 8:00am (PST)
In this webcast, Dr. Thomas Snyder and Dr. Jabran Zahid will discuss how immunosequencing and identification of public T-cell receptor responses can be used to characterize HLA type and make connections of HLA to disease biology, immune response, and immune-driven therapies.
Speaker(s): Thomas Snyder PhD; Jabran Zahid PhD (Microsoft Research)
Topic(s): Using immunosequencing to characterize HLA and its role in disease
July 20-21, 2021
Two day virtual event bringing together those currently working hard to ease the globe out of the COVID-19 pandemic, and to prevent it from happening again.
Speaker: Harlan Robins, PhD; Lance Baldo, MD
Topic(s): Keynote Panel – COVID-19: Where are we now, and what needs to happen next?; Using machine learning to develop clinical tests for infectious diseases
June 14-18, 2021
Precision Medicine in the Era of a Pandemic Recovery
Speaker(s): Julie Rubinstein; Lance Baldo, MD; Sharon Benzeno, PhD; Harlan Robins, PhD
Topic(s): SARS-CoV-2 Vaccines: Updates on Recent Developments and RWD/RWE Results, Novel Technologies to Advance Cell Therapies for Cancer, Using Immune Response Information to Develop Therapeutics in New Disease Areas
May 13th, 2021 @ 12pm (ET)
Virtual Congressional Hearing
This briefing will be hosted by Adaptive Biotechnologies and the Personalized Medicine Coalition in cooperation with Rep. Tom Emmer (R-MN), Rep. Eric Swalwell (D-CA), Sen. Tim Scott (R-SC), and Sen. Kyrsten Sinema (D-AZ).
Cynthia Bens of the Personalized Medicine Coalition will moderate a discussion with leading experts.
Speaker: Lance Baldo, MD
Topic(s): Understanding the Immune Response to COVID-19
May 12th, 2021
This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.
Speaker: Harlan Robins, PhD
Topic: Cell therapy in solid tumors: Freedom of the open road
STAT May 11th, 2021
Biology and technology are converging to change medicine. Join us for the 2021 STAT Health Tech Summit, which will bring you inside this transformation, with probing interviews, lively panels, and exciting demos.
Speaker: Mark Adams, PhD